[144] TERADATA CORPORATION SEC Filing

Rhea-AI Filing Summary

Teradata Corporation notice reports a proposed sale of 75,060 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of approximately $1,580,457.43. The filing lists the seller's acquisition history: ten separate restricted stock vesting events between 02/13/2023 and 03/06/2025 totaling the units underlying the sale, with each grant identified as compensation. The filing states there were 94,500,000 shares outstanding and shows no securities sold by the seller in the past three months.

Positive

• Clear compliance disclosure of the proposed sale under Rule 144 with broker, exchange, and aggregate market value provided
• Acquisition history documented showing shares originated from restricted stock vesting and were granted as compensation
• No securities sold in the past three months by the filer, indicating this is not part of an active selling pattern

Negative

• Limited information on the seller: filer CIK/CCC and contact details are not provided in the text
• No disclosure of a 10b5-1 trading plan or plan adoption date, though the form references such plans

Insights

Securities Analyst

TL;DR Routine insider sale notice: modest volume relative to outstanding shares; no past three-month dispositions reported.

This Form 144 is a standard compliance disclosure for a planned sale under Rule 144. The proposed block of 75,060 shares represents roughly 0.079% of the issuer's reported outstanding common shares (75,060/94,500,000). The reported aggregate market value is listed as $1,580,457.43 and execution is routed through Fidelity on the NYSE. The acquisition history shows the shares were received via restricted stock vesting across multiple dates and were granted as compensation. The filer affirms absence of undisclosed material adverse information. There are no reported sales in the past three months, suggesting this filing is a planned disposition rather than part of an active trading pattern.

Corporate Governance Specialist

TL;DR Compliance-focused filing with clear vesting history; no governance red flags disclosed.

The document provides required transparency about the source of the shares—restricted stock vesting from the issuer—and the non-cash nature of the consideration (compensation). The seller signs the attestation regarding material information and mentions potential applicability of 10b5-1 plans without providing plan details. Because the filing contains only the minimum required disclosures and shows no recent sales, it does not itself indicate governance issues or market-moving events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	75060	1580457.43	94500000	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2023	Restricted Stock Vesting	Issuer			26346	02/13/2023	Compensation
Common	03/01/2023	Restricted Stock Vesting	Issuer			4266	03/01/2023	Compensation
Common	11/09/2023	Restricted Stock Vesting	Issuer			3318	11/09/2023	Compensation
Common	02/12/2024	Restricted Stock Vesting	Issuer			11961	02/12/2024	Compensation
Common	03/01/2024	Restricted Stock Vesting	Issuer			5791	03/01/2024	Compensation
Common	03/06/2024	Restricted Stock Vesting	Issuer			3685	03/06/2024	Compensation
Common	02/12/2025	Restricted Stock Vesting	Issuer			9636	02/12/2025	Compensation
Common	02/27/2025	Restricted Stock Vesting	Issuer			3324	02/27/2025	Compensation
Common	03/01/2025	Restricted Stock Vesting	Issuer			3055	03/01/2025	Compensation
Common	03/06/2025	Restricted Stock Vesting	Issuer			3678	03/06/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Teradata's (TDC) Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 75,060 common shares via Fidelity on the NYSE with an aggregate market value of $1,580,457.43.

How many Teradata shares are outstanding according to the filing?

The filing reports 94,500,000 shares outstanding.

When is the approximate date of the proposed sale listed in the Form 144?

The approximate date of sale is listed as 08/27/2025.

What is the origin of the shares to be sold in Teradata's filing?

All listed shares were acquired through restricted stock vesting from the issuer and were recorded as compensation.

Did the filer report any securities sold in the past three months?

The filing states Nothing to Report for securities sold during the past three months.